62 studies found for:    allergy | Closed Studies | Studies With Results | Switzerland | France
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy
Conditions: Allergic Rhinitis;   Rhinoconjunctivitis
Interventions: Drug: placebo;   Drug: AllerT low dose;   Drug: AllerT full dose
2 Completed
Has Results
Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment
Condition: Birch Pollen Allergy
Intervention:
3 Completed
Has Results
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Conditions: Coronary Artery Disease;   General Anesthetic Drug Allergy;   Coronary Artery Bypass Graft Surgery
Interventions: Drug: Xenon;   Drug: Sevoflurane;   Drug: Propofol
4 Completed
Has Results
EASSI - Evaluation of the Safety of Self-Administration With Icatibant
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
5 Completed
Has Results
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
Condition: HIV Infections
Intervention: Drug: Recombinant interleukin-2 (rIL-2)
6 Completed
Has Results
Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma
Condition: Asthma
Intervention: Drug: BI 1744 CL
7 Completed
Has Results
Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
Condition: Melanoma
Interventions: Drug: Ipilimumab;   Drug: Placebo;   Drug: Dacarbazine
8 Completed
Has Results
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Selexipag;   Drug: Placebo
9 Completed
Has Results
Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
Condition: Allergy
Interventions: Drug: 300 IR (4M);   Drug: 300 IR (2M);   Drug: Placebo
10 Completed
Has Results
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
Conditions: Prostatic Neoplasms;   Neoplasm Metastasis
Interventions: Drug: Aflibercept;   Drug: Placebo (for aflibercept);   Drug: Docetaxel;   Drug: Prednisone or Prednisolone
11 Completed
Has Results
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
Condition: Allergic Asthma
Interventions: Drug: omalizumab at a dose of 0.016mg/kg/IU/mL;   Drug: Placebo
12 Terminated
Has Results
(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Ambrisentan;   Drug: Placebo
13 Active, not recruiting
Has Results
Type 3 Von Willebrand International Registries Inhibitor Prospective Study
Condition: Type 3 Von Willebrand's Disease
Intervention:
14 Completed
Has Results
BUILD 3: Bosentan Use in Interstitial Lung Disease
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Bosentan;   Drug: Placebo
15 Terminated
Has Results
Natalizumab (Tysabri) Re-Initiation of Dosing
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: Natalizumab
16 Completed
Has Results
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: Macugen
17 Completed
Has Results
Methotrexate-Inadequate Response Study
Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: Subcutaneous (SC) Abatacept;   Drug: Intravenous (IV) Abatacept
18 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
19 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
20 Completed
Has Results
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Condition: HIV-1 Infection
Interventions: Drug: FTC/RPV/TDF;   Drug: EFV/FTC/TDF

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years